1
|
Husmann K, Arlt MJ, Muff R, Langsam B,
Bertz J, Born W and Fuchs B: Matrix Metalloproteinase 1 promotes
tumor formation and lung metastasis in an intratibial injection
osteosarcoma mouse model. Biochim Biophys Acta. 1832:347–354. 2013.
View Article : Google Scholar
|
2
|
Khanna C and Hunter K: Modeling metastasis
in vivo. Carcinogenesis. 26:513–523. 2004. View Article : Google Scholar
|
3
|
Sternlicht MD and Werb Z: How matrix
metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol.
17:463–516. 2001. View Article : Google Scholar : PubMed/NCBI
|
4
|
Coussens LM, Fingleton B and Matrisian LM:
Matrix metalloproteinase inhibitors and cancer: trials and
tribulations. Science. 295:2387–2392. 2002. View Article : Google Scholar : PubMed/NCBI
|
5
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
6
|
Cowan RW, Mak IW, Colterjohn N, Singh G
and Ghert M: Collagenase expression and activity in the stromal
cells from giant cell tumour of bone. Bone. 44:865–871. 2009.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Bjørnland K, Flatmark K, Pettersen S,
Aaasen AO, Fodstad O and Maelandsmo GM: Matrix metalloproteinases
participate in osteosarcoma invasion. J Surg Res. 127:151–156.
2005.PubMed/NCBI
|
8
|
Korpi JT, Hagström J, Lehtonen N,
Parkkinen J, Sorsa T, Salo T and Laitinen M: Expression of matrix
metalloproteinases-2, -8, -13, -26, and tissue inhibitors of
metalloproteinase-1 in human osteosarcoma. Surg Oncol. 20:e18–e22.
2011. View Article : Google Scholar : PubMed/NCBI
|
9
|
Mehta PB, Jenkins BL, McCarthy L, Thilak
L, Robson CN, Neal DE and Leung HY: MEK5 overexpression is
associated with metastatic prostate cancer, and stimulates
proliferation, MMP-9 expression and invasion. Oncogene.
22:1381–1389. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ramsay AK, McCracken SR, Soofi M, Fleming
J, Yu AX, Ahmad I, Morland R, Machesky L, Nixon C, Edwards DR,
Nuttall RK, Seywright M, Marquez R, Keller E and Leung HY: ERK5
signalling in prostate cancer promotes an invasive phenotype. Br J
Cancer. 104:664–672. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Cho HJ, Lee TS, Park JB, Park KK, Choe JY,
Sin DI, Park YY, Moon YS, Lee KG, Yeo JH, Han SM, Cho YS, Choi MR,
Park NG, Lee YS and Chang YC: Disulfiram suppresses invasive
ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9
expression. J Biochem Mol Biol. 40:1069–1076. 2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Shintani Y, Maeda M, Chaika N, Johnson KR
and Wheelock MJ: Collagen I promotes epithelial-to-mesenchymal
transition in lung cancer cells via transforming growth factor-beta
signaling. Am J Respir Cell Mol Biol. 38:95–104. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Fallica B, Maffei JS, Villa S, Makin G and
Zaman M: Alteration of cellular behavior and response to PI3K
pathway inhibition by culture in 3D collagen gels. PLoS One.
7:e480242012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Liotta LA, Steeg PS and Stetler-Stevenson
WG: Cancer metastasis and angiogenesis: an imbalance of positive
and negative regulation. Cell. 64:327–336. 1991. View Article : Google Scholar : PubMed/NCBI
|
15
|
Tsuchiya Y, Endo Y, Sato H, Okada Y, Mai
M, Sasaki T and Seiki M: Expression of type-IV collagenases in
human tumor cell lines that can form liver colonies in chick
embryos. Int J Cancer. 56:46–51. 1994. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kim SM, Lee H, Park YS, Lee Y and Seo SW:
ERK5 regulates invasiveness of osteosarcoma by inducing MMP-9. J
Orthop Res. 30:1040–1044. 2012. View Article : Google Scholar : PubMed/NCBI
|